Risk factor
Poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series,...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Target Price
The average target price of 1061.HK is 6.8 and suggests 54% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell